Weight Management PGDs: Governance and Patient Assessment

A weight management service requires individual assessment, ongoing support and a clear legal framework for each medicine supplied. A Patient Group Direction (PGD) is one possible mechanism in limited situations, but a service must not assume that a single document is appropriate for every medicine, patient or stage of treatment.

What a PGD does

A PGD is a written instruction for specified registered professionals to supply or administer a named medicine to people who meet a defined set of criteria. It is not a prescription or a general authority to provide treatment. The organisation must confirm that the mechanism is appropriate and that the document is current, authorised and applicable to its setting.

The practitioner must follow the precise criteria, medicine, formulation and quantity in the PGD. If a person does not meet an inclusion criterion or meets an exclusion criterion, they must not be treated under that PGD. Follow the documented referral pathway or use another appropriate legal mechanism.

Assessment and follow-up

A responsible pathway considers the person’s health history, current medicines, relevant risks, treatment goals and support needs. Use the current PGD, product information and relevant guidance to decide what information is required. Discuss the benefits, risks, realistic expectations and follow-up plan in a respectful, non-stigmatising way. Record the assessment, decision, consent, advice and arrangements for review.

A PGD does not provide authority to adjust the dose of medicine already in a person’s possession. Where individual dose changes or complex monitoring are needed, the organisation should establish an appropriate prescribing or other lawful pathway. The NHS Specialist Pharmacy Service explains this distinction.

Prepare the team and governance

Confirm practitioner eligibility, individual authorisation, training and competence; define escalation for adverse effects and referrals; and maintain version control and audit processes. Check the current regulatory and product information before service launch and whenever guidance changes.

AHT’s Weight Loss PGD product page lists several medicines and personal or premises options. Listing a medicine does not establish that every formulation, use or patient is covered by a particular PGD. Ask AHT for the current documents and verify suitability, authorisation and pathway requirements before use.

Explore the product: https://ahtraining.co.uk/product/weight-loss-pgd/

Sources and further reading
NHS SPS, introduction to PGDs: https://sps.nhs.uk/articles/introduction-to-pgds/
NHS SPS, dose adjustments: https://sps.nhs.uk/articles/understanding-why-pgds-cannot-be-used-for-dose-adjustments/
MHRA, GLP-1 medicines information: https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know

For healthcare professionals. This overview does not replace an authorised PGD, product information or local clinical governance. Clinical review is required before publication.

Facebook
Twitter
LinkedIn
Telegram
Comments